Reaction-contingency based bipartite Boolean modelling
2013 (English)In: BMC Systems Biology, E-ISSN 1752-0509, Vol. 7, article id 58
Article in journal (Refereed) Published
Abstract [en]
Background: Intracellular signalling systems are highly complex, rendering mathematical modelling of large signalling networks infeasible or impractical. Boolean modelling provides one feasible approach to whole-network modelling, but at the cost of dequantification and decontextualisation of activation. That is, these models cannot distinguish between different downstream roles played by the same component activated in different contexts.
Results: Here, we address this with a bipartite Boolean modelling approach. Briefly, we use a state oriented approach with separate update rules based on reactions and contingencies. This approach retains contextual activation information and distinguishes distinct signals passing through a single component. Furthermore, we integrate this approach in the rxncon framework to support automatic model generation and iterative model definition and validation. We benchmark this method with the previously mapped MAP kinase network in yeast, showing that minor adjustments suffice to produce a functional network description.
Conclusions: Taken together, we (i) present a bipartite Boolean modelling approach that retains contextual activation information, (ii) provide software support for automatic model generation, visualisation and simulation, and (iii) demonstrate its use for iterative model generation and validation.
Place, publisher, year, edition, pages
London, UK: BioMed Central (BMC), 2013. Vol. 7, article id 58
National Category
Bioinformatics (Computational Biology)
Identifiers
URN: urn:nbn:se:oru:diva-116591DOI: 10.1186/1752-0509-7-58ISI: 000321744800001PubMedID: 23835289Scopus ID: 2-s2.0-84879801760OAI: oai:DiVA.org:oru-116591DiVA, id: diva2:1904265
Funder
EU, FP7, Seventh Framework Programme, 201142
Note
This work was supported by a grant from the European Commission 7th Framework Programme: UNICELLSYS (Contract No. 201142 to EK), and grants from the German Ministry for Education and Research (BMBF): SysMO2 project Translucent 2 (FKZ0315786A to EK), Drug-iPS (FKZ 0315398 F to EK) and e: Bio Cellemental (FKZ0316193 to MK).
2024-10-082024-10-082025-01-24Bibliographically approved